Bringing you the latest cutting-edge research and commentary in bioscience.

Cell & Gene Therapy Insights

Cell & Gene Therapy Insights

Interview
Spotlight Article

Gene editing as a key enabler of allogeneic cell therapy

Trends and advances in gene therapy delivery and gene editing

Torsten Meissner

TORSTEN MEISSNER obtained his PhD in biology at Free University, Berlin and moved on to do postdoctoral research in immunology and stem cell research at Dana-Farber Cancer Institute and Harvard University in Cambridge, Massachusetts. Torsten is currently an Instructor in the Department of Surgery at Beth Israel Deaconess Medical Center in Boston, a Harvard Medical School affiliated research hospital. His research combines genome, cell, and tissue engineering with the overall goal to take down the immune barrier to transplantation. Torsten is currently developing methods to generate immune-silent, living blood vessels from human induced pluripotent stem cells (iPSC) that can be used for disease modeling and vascular reconstruction.

DOI: 10.18609/cgti.2020.060
Citation: Cell & Gene Therapy Insights 2020; 6(4), 517–523
Open access
This content is restricted to registered users. Click here to Register or Login here.
Twitter IconVisit Our Blog